Pulmonary Hypertension (PH) (DBCOND0051788)

Identifiers

Synonyms
Pulmonary Hypertension / Pulmonary hypertensions / Hypertension pulmonary / Pulmonary hypertension, unspecified / Pulmonary hypertension (disorder) / Pulmonary hypertension NOS / Hypertension, Pulmonary

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Diltiazem
A calcium channel blocker used to treat hypertension and to manage chronic stable angina.
Nifedipine
A dihydropyridine calcium channel blocker indicated for the management of several subtypes of angina pectoris, and hypertension.
Nitric Oxide
A vasodilating agent used in the treatment of hypoxic respiratory failure in premature neonates.
Oxygen
An essential element for human survival used in clinical conditions in which there is a lack of oxygen, such as, but not limited to, anoxia, hypoxia or dyspnea.
Treprostinil
A prostacyclin vasodilator for the treatment of pulmonary arterial hypertension to relieve exercise associated symptoms and to prevent clinical deterioration after stopping epoprostenol.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT01347216
COMPERA / COMPERA-KIDSNo drug interventionsNot AvailableNot Availablerecruiting
NCT00862043
Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Diseasetreatment4completed
NCT03177603
A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)treatment2completed
NCT02580903
Pulmonary Hypertension in Patients With Myeloproliferative NeoplasmsNo drug interventionsNot AvailableNot Availablecompleted
NCT02435303
Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)treatment2 / 3terminated
NCT04459364
The Prevalence of Pulmonary Hypertension in Patients With COVID-19.No drug interventionsNot AvailableNot Availablecompleted
NCT03089164
Postural Changes During Right Heart CatheterizationNo drug interventionsNot AvailableNot Availableterminated
NCT03185364
The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPDtreatmentNot Availableunknown_status
NCT06388421
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03905421
Quality of Life Assessed With the PAH SYMPACT QuestionnaireNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00235521
Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass SurgerytreatmentNot Availablecompleted
NCT00960921
Study of the Effects of Iron on Lung Blood Pressure at High Altitudetreatment2withdrawn
NCT02760121
AZ, MZ, and the Pulmonary System Response to Hypoxiabasic_science4completed
NCT00424021
Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertensiontreatment2completed
NCT00952302
Study of the Effects of Iron Levels on the Lungs at High Altitudebasic_scienceNot Availablecompleted
NCT05566002
Artificial Intelligence-assisted Evaluation of Pulmonary HYpertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT00549302
Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungstreatment3completed
NCT01529502
Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Settingbasic_science2completed
NCT04373902
Physiological-based Cord Clamping in Congenital Diaphragmatic HerniaNo drug interventionspreventionNot Availablerecruiting
NCT02778802
Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVRNo drug interventionsNot AvailableNot Availableunknown_status
NCT01036802
Anticoagulation For Pulmonary Hypertension in Sickle Cell Diseasetreatment2terminated
NCT02482402
Iloprost for Bridging to Heart Transplantation in PHtreatment2withdrawn
NCT04901884
PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction EvaluationdiagnosticNot Availablerecruiting
NCT03139084
Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial HypertensionNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01615484
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant SuitabilityNo drug interventionstreatmentNot Availablecompleted
NCT04231084
Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxidediagnostic4completed
NCT02216279
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary HypertensionNo drug interventionsdiagnostic2completed
NCT04378179
Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS)No drug interventionsNot AvailableNot Availableunknown_status
NCT03592979
Acute Exposure of Simulated Hypoxia on Heart Rate and Ventilation During ExerciseNo drug interventionstreatmentNot Availablecompleted
NCT03365479
Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertensionbasic_scienceNot Availablecompleted
NCT00414687
Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertensiontreatment2completed
NCT02265887
The Pan African Pulmonary Hypertension Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00159887
Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertensiontreatment3completed
NCT05873387
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic StethoscopeNo drug interventionsNot AvailableNot Availablerecruiting
NCT05186987
Visa-versa! Breaking Instead of Pushing the Pedals-ANo drug interventionstreatmentNot Availablecompleted
NCT02688387
A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjectstreatment1completed
NCT00360087
A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Studytreatment3terminated
NCT04152187
Effects of Inspiratory Muscle Training in Patients With Pulmonary HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT02061787
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT06249633
Inhaled Nitric Oxide for ARDS-related Pulmonary Hypertensiontreatment0not_yet_recruiting
NCT02865733
Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgeryprevention3completed
NCT03385733
Inspiratory Muscle Training in Pulmonary HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT00517933
Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosistreatment3completed
NCT01380054
Pulmonary Hypertension, Quality of Life and Psychosocial FactorsNo drug interventionsNot AvailableNot Availablecompleted
NCT04991454
Xenon MRI Pulm HypertensionNo drug interventionsdiagnostic2recruiting
NCT01065454
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunctiontreatment2active_not_recruiting
NCT00927654
Iloprost in High Risk Cardiac Surgical Patientstreatment3completed
NCT06079151
Hemodynamic Effect of Nasal High-flow in Patients Suspected or Followed for a Precapillary Pulmonary HypertensionNo drug interventionstreatmentNot Availablerecruiting
NCT03022851
The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary HypertensionNo drug interventionstreatmentNot Availableunknown_status
NCT01310751
Study of Inhaled Iloprost in Pediatric Pulmonary Hypertension (PH) After Surgeryprevention2 / 3completed
NCT01960153
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damageprevention3withdrawn
NCT03581877
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PEtreatment4completed
NCT03762577
Effects of Ground-based Walking Training in Pulmonary HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT00819377
Milrinone Inhaled in Cardiac Surgerytreatment2completed
NCT02278445
Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)No drug interventionsdiagnosticNot Availablewithdrawn
NCT01202045
Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis PatientsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04279145
Evaluation of Echocardiographic Indices and Blood Biomarkers in Group 1 Pulmonary HypertensionNo drug interventionsdiagnosticNot Availableunknown_status
NCT04432545
Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary InvolvementNo drug interventionsNot AvailableNot Availableavailable
NCT01568645
Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Diseasetreatment1withdrawn
NCT03763045
Sildenafil in Hemodialysis Patients With Pulmonary Hypertensiontreatment2 / 3unknown_status
NCT00666198
Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)Not AvailableNot Availablecompleted
NCT01516398
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary DysplasiaNo drug interventionsNot AvailableNot Availablecompleted
NCT06336798
Bioenergetic Effect of Pioglitazone in CLD-PHtreatment2not_yet_recruiting
NCT03726398
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PHprevention2 / 3unknown_status
NCT00091598
ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)treatment3completed
NCT05935605
Pulmonary Hypertension in Left Heart DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT00593905
Pharmacogenomics in Pulmonary Arterial HypertensionNot AvailableNot Availablewithdrawn
NCT02252705
Mexican Registry of Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT03593005
Acute Exposure to High Altitude on SymptomsNo drug interventionspreventionNot Availablecompleted
NCT00004805
Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden DeathNo drug interventionseducational_counseling_trainingNot Availablecompleted
NCT01055405
Study of Sildenafil Effects in Combination With Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Associated Pulmonary Hypertensiontreatment4completed
NCT00004497
Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertensiontreatment3completed
NCT02963597
Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea.No drug interventionstreatmentNot Availablecompleted
NCT03593083
Acute Excposure of High Altitude on ECG and Non-invasive Blood Pressure.No drug interventionspreventionNot Availablecompleted
NCT04053361
Catheter Ablation of Atrial Fibrillation in Patients With Pulmonary Hypertension Hypertension: a Randomised StudyNo drug interventionstreatmentNot Availablecompleted
NCT03707561
RUS-registry of PHNo drug interventionsNot AvailableNot Availableunknown_status
NCT04623528
Characterization of the Liver Parenchyma Using Parametric T1 and T2 Magnetic Resonance RelaxometryNo drug interventionsNot AvailableNot Availablecompleted
NCT05980728
Connective Tissue Disease Patients With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01959828
Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgerytreatment3completed
NCT02774928
Clinical Profile of Patients With Pulmonary Hypertension Due to Lung Diseases ( Single Center Experience)No drug interventionsNot AvailableNot Availableunknown_status
NCT05475028
Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors (PRESMET)No drug interventionsNot AvailableNot Availablecompleted
NCT01729611
Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT00302211
The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertensiontreatment3terminated
NCT02886793
Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjectsdiagnostic1 / 2completed
NCT03854071
Development of Novel Physiological CMR Methods in Health and DiseaseNo drug interventionsotherNot Availablesuspended
NCT01389271
Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 YearsNot AvailableNot Availablecompleted
NCT02368171
Role of Heme-oxygenase (HO) and Nitric Oxide (NO) Pathway in Patients With Obstructive Sleep Apnea (OSA) and Pulmonary Hypertension (PH)No drug interventionsNot AvailableNot Availableunknown_status
NCT05442671
iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PHNo drug interventionstreatmentNot Availablerecruiting
NCT01423071
Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of LifeNo drug interventionsNot AvailableNot Availablecompleted
NCT01281371
Observation Study of the Medication Switch at Patients Treated With Sitaxentan to a Regime Without SitaxentanNo drug interventionsNot AvailableNot Availablecompleted
NCT00270478
Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemiatreatment1completed
NCT01320878
Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Diseasetreatment2completed
NCT04084678
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PHtreatment3terminated
NCT01437878
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)treatment2terminated
NCT00893178
Impact of Polymorphism on Pulmonary Pressure in Subjects With Pulmonary Hypertension of Different CauseNo drug interventionsNot AvailableNot Availablecompleted
NCT03637088
Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo)No drug interventionspreventionNot Availablecompleted
NCT01642407
Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertensiontreatment4completed
NCT00491309
Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary HypertensionNo drug interventionstreatmentNot Availableunknown_status
NCT02742909
Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Diseasetreatment4completed
NCT03809156
Upfront Combination Pulmonary Arterial Hypertension Therapytreatment4unknown_status
NCT02821156
Study on the Use of Inhaled NO (iNO)No drug interventionsNot AvailableNot Availablecompleted
NCT01172756
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunctiontreatment2terminated
NCT06197256
Cardiac Dysfunction in Critically Ill Covid-19 PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06386185
Developing the Probability Algorithm for Pulmonary Hypertension EchocardiographyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01950585
Hydroxyurea in Pulmonary Arterial Hypertensiontreatment0withdrawn
NCT00185315
Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertensiontreatment3completed
NCT05553015
A Real-World Registry Investigating TReprostInil sodiUM in Pulmonary Hypertension (Re-TRIUMPH)No drug interventionsNot AvailableNot Availablerecruiting
NCT04055415
Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial HypertensionNo drug interventionstreatment1 / 2unknown_status
NCT00583115
Safety Study of Gleevec® in Children With Pulmonary Hypertensiontreatment2terminated
NCT00173537
Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary HypertensionNo drug interventionsdiagnosticNot Availableunknown_status
NCT02191137
Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION)treatment4completed
NCT03649932
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and DosingNo drug interventionstreatment1completed
NCT05356052
Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary FibrosisNo drug interventionsNot AvailableNot Availableavailable
NCT01342952
Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529treatment2completed
NCT00718952
The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertensiontreatment3completed
NCT02133352
Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunctiontreatment4completed
NCT00820352
Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertensiontreatment3completed
NCT04175600
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertensiontreatment3active_not_recruiting
NCT02267200
The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHDNo drug interventionsNot AvailableNot Availablecompleted
NCT05595200
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04019600
Screening of Pulmonary Hypertension in Methamphetamine AbusersNo drug interventionsNot AvailableNot Availablesuspended
NCT01571700
Investigation of Dysynchrony in Patients With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT03039959
Predictive Value of Renal Venous Flow Profiles for Adverse Outcomes in Right Heart FailureNo drug interventionsNot AvailableNot Availablecompleted
NCT03195959
Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT00739375
The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.No drug interventionsbasic_science1completed
NCT03574675
Acute Exposure of Simulated Hypoxia on Cardiac OutputNo drug interventionspreventionNot Availablecompleted
NCT00872170
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertensiontreatment2 / 3completed
NCT00519870
Losartan Therapy in Pulmonary Hypertensiontreatment3completed
NCT06495970
Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study)No drug interventionstreatmentNot Availablerecruiting
NCT02894970
A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial SaturationNo drug interventionsNot AvailableNot Availableunknown_status
NCT00458042
Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfactiontreatment4terminated
NCT01324999
Tadalafil for Sarcoidosis Associated Pulmonary Hypertensiontreatment2 / 3completed
NCT02752399
Six Minutes Walk Test and Shuttle Walk Test in Eisenmenger SyndromeNo drug interventionsNot AvailableNot Availableunknown_status
NCT00147199
Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)treatment3completed
NCT06038149
Improving Pulmonary Hypertension Screening by EchocardiographyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00595049
Pulmonary Artery Remodelling With Bosentantreatment4completed
NCT00377949
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01862536
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Diseasetreatment2completed
NCT00359736
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosistreatment2completed
NCT06299436
Hemodynamic Assessment of underLying myocyTe Function in Right Heart FailureNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01156636
Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failuretreatment2 / 3completed
NCT01917136
11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertensiondiagnostic2completed
NCT02290613
Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)treatment2completed
NCT05133713
Ventilation and Perfusion Scan in Pulmonary Embolism Following Catheter Directed Thrombectomy Versus Anticoagulation AloneNo drug interventionsNot AvailableNot Availableunknown_status
NCT00845013
Epidemiology and Pathogenesis of HIV-Associated Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT05767918
StratosPHere (Non-interventional Study)No drug interventionsNot AvailableNot Availablecompleted
NCT00125918
PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertensiontreatment3completed
NCT02790918
Diagnosis of Pulmonary Hypertension Using Cardiac Magnetic Resonance ImagesNo drug interventionsNot AvailableNot Availablecompleted
NCT01948518
Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung DiseasediagnosticNot Availablecompleted
NCT05727618
The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac SurgeryNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00554619
A Study to Evaluate GSK1325760A - a Long-Term Extension Studytreatment3completed
NCT05096819
Evaluation of the Usefulness of Adopting Remote, Mobile-based 6MWT Among Hospital Outpatients (the 6-APPnow), Within the Constraints Imposed by the SARS-COV2 PandemicNo drug interventionsNot AvailableNot Availablecompleted
NCT03974919
Preoperative Pulmonary Systolic Pressure and Outcome After Non-cardiac Surgery:Threshold AnalysisNo drug interventionsNot AvailableNot Availablecompleted
NCT01646541
Symptomatic Pulmonary Arterial Hypertension After Mitral Valve SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT03149341
MRI and Computational Simulation Cardiology StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04663217
Exercise Hemodynamic, Right Ventricular Coupling and Echocardiography in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT02594917
Genetic and Environmental Determinants That Control Metabolism in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT02829034
Targeting Right Ventricle in Pulmonary Hypertension Gileadtreatment4completed
NCT01179334
Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.treatment2completed
NCT06023134
Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart FailureNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04524234
Cardiac Dysfunction in Critically Ill Patients With COVID-19No drug interventionsNot AvailableNot Availablecompleted
NCT03154034
Cardiopulmonary Exercise Testing in Severe Mitral RegurgitationNo drug interventionsNot AvailableNot Availablecompleted
NCT01317134
Endothelial Function in Patients With Pulmonary Arterial HypertensionNo drug interventionsdiagnosticNot Availablecompleted
NCT02377934
Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02220634
Regadenoson for Acute Vasoreactivity Testing in Pulmonary HypertensiontreatmentNot Availableterminated
NCT00477724
Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH )After Endarterectomy and Influence of Exercise and Respiratory TherapyNo drug interventionstreatmentNot Availableunknown_status
NCT02630316
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFEtreatment2 / 3completed
NCT02345616
Role of the Nitric Oxide (NO) in Pre-oxygenation Before Anesthetic Induction in Patients With a Pulmonary Hypertension in Cardiac Surgery. Pilot Study of Feasibilitytreatment2unknown_status
NCT04599816
Levosimendan Administration in Pulmonary HypertensionpreventionNot Availablecompleted
NCT02885116
Effect of Nasal Highflow on Right Heart FunctionNo drug interventionstreatmentNot Availablecompleted
NCT04559516
Remote Exercise Program Delivery Using a Mobile Application for Pulmonary Arterial HypertensionNo drug interventionstreatmentNot Availablewithdrawn
NCT01247116
First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT04499196
Glucocorticoids and Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT00023296
Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertensiontreatment1completed
NCT00313196
Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)treatment3terminated
NCT01370096
Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertensiontreatment2terminated
NCT00454558
An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertensiontreatment2completed
NCT01042158
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosistreatment4completed
NCT02220335
Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart FailuretreatmentNot Availablecompleted
NCT05136235
Pulmonary Hypertension in Extremely Preterm InfantsNo drug interventionsscreeningNot Availablenot_yet_recruiting
NCT02562235
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)treatment3active_not_recruiting
NCT05458635
Predictors of Pulmonary Hypertension in Patients With Hypersensitivity PneumonitisNo drug interventionsdiagnosticNot Availablecompleted
NCT01894035
Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for InhalationNot AvailableNot Availablecompleted
NCT01387035
Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00527163
Role of Nitric Oxide in MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT05372263
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05299463
Remote Exercise Testing in Patients With Pulmonary HypertensionNo drug interventionsdiagnosticNot Availableunknown_status
NCT00086463
Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)No drug interventionstreatment2completed
NCT00840463
Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentandiagnostic4terminated
NCT04095286
Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult ParticipantsNo drug interventionstreatment1completed
NCT01839786
Evaluation of Lung Doppler Signals in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableterminated
NCT03683186
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extensiontreatment3enrolling_by_invitation
NCT05699486
A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass SurgeryNo drug interventionstreatment2recruiting
NCT01361139
Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)No drug interventionsNot AvailableNot Availablecompleted
NCT00703339
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosistreatment2terminated
NCT05649722
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)treatment2 / 3recruiting
NCT04683822
Telerehabilitation in Patients With Pulmonary HypertensionNo drug interventionssupportive_careNot Availableunknown_status
NCT03564522
Image-based Multi-scale Modeling Framework of the Cardiopulmonary System: Longitudinal Calibration and Assessment of Therapies in Pediatric Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT01409122
Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjectstreatment1completed
NCT05776225
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier DetectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT02587325
Phase 1/1b Study With Nab-sirolimus for Patients With Severe Pulmonary Arterial Hypertensiontreatment1completed
NCT00352430
Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertensiontreatment1completed
NCT04663230
Right Atrial Fibrosis in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT03269630
New Orleans Pulmonary Hypertension BiobankNo drug interventionsNot AvailableNot Availablerecruiting
NCT04101630
Activity Monitoring in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT01185730
Prospective Longitudinal Study of Patients With Idiopathic Pulmonary Arterial Hypertension, Family or Taking AnorecticsNo drug interventionspreventionNot Availablecompleted
NCT03304548
Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) SubjectsNo drug interventionsNot AvailableNot Availablecompleted
NCT02246348
Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)No drug interventionsdiagnosticNot Availableterminated
NCT03883048
Idiopathic Bronchiectasis and Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT00314548
Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary HypertensiontreatmentNot Availablecompleted
NCT01913457
Measurements and Characterization of Doppler Signals From the Right Chest in Pediatric and Adult PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT00080457
Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertensiontreatment3completed
NCT00205426
Natrecor for Pulmonary Hypertension in Lung Transplantsprevention4completed
NCT00830726
Water- and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT06405126
Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04912726
Endovenous Sildenafil Early Management in Newborns Pulmonary HypertensionpreventionNot Availableunknown_status
NCT00825266
Insulin Resistance in Pulmonary Arterial Hypertensiontreatment2terminated
NCT03821766
Haemodynamic Abnormalities Recorded With Cardiac Catheterization Along With Body's Surface Micro-accelerometers (KT-KCG)No drug interventionsNot AvailableNot Availablewithdrawn
NCT05731466
Exercise Right Ventricular Coupling in HFpEFNo drug interventionsdiagnosticNot Availablerecruiting
NCT05935865
Monitoring of the Influence of Approved PH-therapies RV-PA CouplingNo drug interventionsNot AvailableNot Availablerecruiting
NCT05205265
Rivet PVS Therapy in Group 2 PH-HFpEFNo drug interventionstreatmentNot Availablewithdrawn
NCT00384865
A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertensiontreatment2terminated
NCT01462565
Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)treatment4completed
NCT02545465
A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical PracticeNot AvailableNot Availablecompleted
NCT01352065
Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administrationbasic_science2 / 3completed
NCT06250374
Assessment of the Cerebral Perfusion During the Period of Deep Hypothermia at 18°C in Patient Undergoing Pulmonary Endarterectomy Surgery.No drug interventionsotherNot Availablerecruiting
NCT03673774
Impedancemetry in Patients Monitored for Pulmonary HypertensionNo drug interventionspreventionNot Availableterminated
NCT00041574
Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxidetreatment2terminated
NCT01728220
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPDNo drug interventionstreatment2completed
NCT00777920
Study of Ambrisentan in Participants With Pulmonary Hypertensiontreatment3completed
NCT02791282
CTEPH DIAGNOSIS Europe - MRINo drug interventionsdiagnostic3unknown_status
NCT03787082
Chlorhexidine Mouthwash and Oral Nitrate in Adults With Pulmonary Hypertensiontreatment1withdrawn
NCT02558582
Effect of Exercise Training in Patients With Pulmonary HypertensionNo drug interventionstreatmentNot Availablerecruiting
NCT02981082
Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertensiontreatment1terminated
NCT00492531
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Diseasetreatment2terminated
NCT05332873
Rivet PVS Therapy in Group 2 PH-HFpEF CanadaNo drug interventionstreatmentNot Availablewithdrawn
NCT06327373
A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemiatreatment1 / 2not_yet_recruiting
NCT03637127
Acute Exposure of Simulated Hypoxia on Cognitive FunctionNo drug interventionspreventionNot Availablecompleted
NCT00963027
Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostiniltreatment1completed
NCT01406327
Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)Not AvailableNot Availablecompleted
NCT00469027
Pulmonary Hypertension: Assessment of Cell TherapyNo drug interventionsNot Available1completed
NCT04756076
Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00458276
Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgerytreatment3terminated
NCT00005776
Inhaled Nitric Oxide Study for Respiratory Failure in Newbornstreatment3terminated
NCT05812976
Novel Index (PIMR) in PAHNo drug interventionsNot AvailableNot Availablerecruiting
NCT03835676
Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertensionother4recruiting
NCT01051960
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentantreatment4completed
NCT03135860
Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygentreatment0terminated
NCT00373360
Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulintreatment4completed
NCT02825160
Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)Not AvailableNot Availablecompleted
NCT02647060
The Exercise Capacity and Quality of Life in the Patients With IPAH and Secondary PHNo drug interventionsNot AvailableNot Availablecompleted
NCT04945460
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)treatment2recruiting
NCT03754660
This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)No drug interventionsbasic_science1completed
NCT02223494
Safety of Terbogrel in Patients With Primary Pulmonary Hypertensiontreatment2terminated
NCT02858791
MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT02117791
Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )Not AvailableNot Availablecompleted
NCT04885491
A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary HypertensionNo drug interventionstreatment1 / 2withdrawn
NCT00981591
Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patientstreatment1 / 2withdrawn
NCT02743091
Idiopathic Pre-capillary Pulmonary Hypertension in ESKD PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04450862
Anxiety Self-management Intervention for Pulmonary HypertensionNo drug interventionsotherNot Availableunknown_status
NCT01787162
Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT04697862
Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension Receiving SildenafilNo drug interventionstreatmentNot Availablecompleted
NCT03037580
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fractiontreatment3terminated
NCT06145880
ADOPT: Improving Diagnosis of Pulmonary Hypertension With AI and EchoNo drug interventionsNot AvailableNot Availablerecruiting
NCT03476629
Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension.No drug interventionstreatmentNot Availableunknown_status
NCT04083729
Persistent Pulmonary Hypertension After Percutaneous Mitral CommissurotomyNo drug interventionstreatmentNot Availableunknown_status
NCT02007629
Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitortreatment3completed
NCT00910429
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertensiontreatment3completed
NCT00879229
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosistreatment3terminated
NCT02374229
Ablation of the Pulmonary Artery With High Pulmonary Hypertension During Mitral Valve SurgeryNo drug interventionstreatment1unknown_status
NCT01539889
Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary CirculationNo drug interventionsdiagnostic1completed
NCT04636892
Evaluating Infrasonic HemodynographyNo drug interventionsdiagnosticNot Availablerecruiting
NCT06254092
Effect of Tourniquet Binding of Cervical on the Blood Volume of Amniotic Fluid in Cesarean SectionNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT00575692
Magnetic Resonance Imaging in the Diagnosis of Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT03197792
Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary EndarterectomyNo drug interventionsscreeningNot Availableunknown_status
NCT04600492
THERAPY-HYBRID-BPA Trialsupportive_care2recruiting
NCT03309592
Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertensiontreatment4withdrawn
NCT01427192
Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertensiontreatment2completed
NCT01758744
Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1treatment1completed
NCT00350844
Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertensiontreatment1 / 2terminated
NCT02729844
Neolifes Heart - Pulmonary Hypertension in Preterm ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT00335244
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgeryprevention3completed
NCT02298244
Safety Procedure Pulmonary Artery Denervation in Addition to Pulmonary Vein Isolation Combined With Ganglionated Plexi Ablation in Patients With Persistent Atrial Fibrillation and Pulmonary HypertensionNo drug interventionstreatmentNot Availableunknown_status
NCT03637140
Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo) Under ExerciseNo drug interventionspreventionNot Availablecompleted
NCT06129240
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PHNo drug interventionsNot AvailableNot Availablerecruiting
NCT03217240
Integrated Computational modelIng of Right Heart Mechanics and Blood Flow Dynamics in Congenital Heart DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT00730067
Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertensiontreatment4withdrawn
NCT04654767
Inflammatory Profiling in Chronic Lung DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT00864201
A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Diseasetreatment3unknown_status
NCT04903704
Pulmonary Hypertension and Measurement of Exercise Capacity RemotelyNo drug interventionstreatmentNot Availablecompleted
NCT05496504
Pulmonary Hypertension and ArrhythmiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00677872
An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Diseasetreatment2terminated
NCT06365372
Circulating MrgD in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT02651272
Macitentan in Pulmonary Hypertension of Sickle Cell Diseaseother2terminated
NCT05082272
The Role of Transthoracic Echocardiography in Diagnosis of Pulmonary Hypertension of Infants With Bronchopulmonary DysplasiaNo drug interventionsNot AvailableNot Availablecompleted
NCT02603068
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosistreatment2withdrawn
NCT00380068
Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertensiontreatment3completed
NCT00679068
Effects of Bosentan on Respiratory MechanicsNot Available4terminated
NCT05901168
Acute Responses of Active Video Games and Traditional Exercise Program in in Patients With Pulmonary HypertensionNo drug interventionstreatmentNot Availablerecruiting
NCT02980068
A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fractiontreatment1completed
NCT03061669
Respiratory Monitoring During Right HeartNo drug interventionsNot AvailableNot Availableunknown_status
NCT01197469
Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension?treatment2completed
NCT02752269
Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT05838846
Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgerytreatment2 / 3active_not_recruiting
NCT01491646
Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT03310346
Registry of Preterm Newborns With Severe Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT04706546
Hemodynamic Effects During Exercise in Patients With Pulmonary Hypertension Receiving SildenafilNo drug interventionsotherNot Availablecompleted
NCT03012646
Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPDtreatment2withdrawn
NCT00091546
Genetic and Environmental Characteristics of Primary Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT02053246
Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failuretreatment4terminated
NCT03345212
A Randomized Controlled Multicenter Trial of Exercise Training in Pulmonary Hypertension in European CountriesNo drug interventionsdiagnosticNot Availablecompleted
NCT00948012
Exercise-induced Pulmonary Hypertension in Patients With Sickle-cell AnemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT03542812
L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasiaother0terminated
NCT00808912
Does Sildenafil Increase Exercise Performance in Air Pollution?basic_scienceNot Availablecompleted
NCT04329312
Differential Diagnosis of Pulmonary Hypertension With Automated Image AnalysisNo drug interventionsNot AvailableNot Availableterminated
NCT00853112
A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertensiontreatment2terminated
NCT03169010
Registration Study for Rare Type of Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT01479010
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertensiontreatment1 / 2terminated
NCT03198910
Retrospective Data Analysis of Data From the Zurich PH RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT01839110
Targeting the Right Ventricle in Pulmonary Hypertensiontreatment4completed
NCT00796510
Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safetytreatment3terminated
NCT01364181
The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patientstreatment3completed
NCT05699681
Correlation of Right Atrial Strain With Pulmonary Hypertension, Right Ventricular Function And Outcome In Pediatric PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01457781
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)treatment2completed
NCT01616381
Sildenafil Versus Placebo in Chronic Heart Failuretreatment3unknown_status
NCT00863681
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertensiontreatment3completed
NCT01393795
Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patientstreatment2completed
NCT03581695
Inflammatory Biomarkers of Pediatric Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT06526195
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00960895
Pulmonary Hypertension in LymphangioleiomyomatosisNo drug interventionsNot AvailableNot Availablecompleted
NCT05785195
A Mechanistic Study of Inhaled Nitric Oxide in COPDNo drug interventionstreatmentNot Availablerecruiting
NCT03001414
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCsNo drug interventionstreatment2 / 3active_not_recruiting
NCT05867914
Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILDNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00370214
REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease ManagementNo drug interventionsNot AvailableNot Availablecompleted
NCT03045614
Kidney Disease and Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT03044314
Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertensiondiagnostic4terminated
NCT01451255
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance ImagingNo drug interventionsNot AvailableNot Availablecompleted
NCT01971450
Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary HypertensionNot AvailableNot Availablecompleted
NCT04654650
Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04718350
Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous AgentspreventionNot Availablerecruiting
NCT00694850
Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)treatment2active_not_recruiting
NCT01212523
Effects of Propofol and Isoflurane on Pulmonary Vascular Resistancediagnostic4completed
NCT06573723
Institutional Registry of Rare DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00926523
Biomarkers in the Evaluation of Chronic Lung DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04480723
A Study for the Identification of Biomarker Signatures for Diagnosis of Pulmonary Hypertension (PH) in Participants at Low or Intermediate Probability of PH Undergoing Cardiac Magnetic Resonance ImagingNo drug interventionsdiagnostic0completed
NCT03496623
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)treatment3terminated
NCT03438123
Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT CameraNo drug interventionsotherNot Availablecompleted
NCT04578223
Platelet Reactivity and Treatment With Prostacyclin Analogues in Pulmonary Arterial HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT00016523
Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failuretreatment3terminated
NCT00561223
Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)treatmentNot Availablecompleted
NCT03267108
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertensiontreatment3terminated
NCT04909008
Exercise Training to Improve Cardiopulmonary Hemodynamics in Heart Failure PatientsNo drug interventionsotherNot Availablerecruiting
NCT00759408
The Role of Endothelin in Pulmonary Hypertensiontreatment2completed
NCT05747508
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosistreatment2unknown_status
NCT06331208
Mechanisms of Pulmonary Vascular Dysfunction in Heart FailureNo drug interventionsNot AvailableNot Availablerecruiting
NCT03194438
Urban Zen Integrative Therapy for Persons With Pulmonary HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT00495638
Pulmonary Hypertension, Hypoxia and Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00145938
Sildenafil and Pulmonary Artery Pressuretreatment2terminated
NCT04633538
Evaluation of a New 6 Minute Walk Test Smartphone App in Patients With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT00439543
Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosistreatment2 / 3unknown_status
NCT05337943
Cognitive Behavioral Therapy and Light TherapyNo drug interventionstreatmentNot Availablecompleted
NCT04078243
Feasibility of Novel Clinical Trial Infrastructure, Design and Technology for Early Phase Studies in Patients With Pulmonary Hypertension (FIT-PH)No drug interventionsNot AvailableNot Availablerecruiting
NCT01210443
Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patientstreatment3terminated
NCT01275703
Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Exercise TestingNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03780803
Effect of Home Rehabilitation on State of Patients With PAH, HFREF and IHDNo drug interventionsotherNot Availablecompleted
NCT02554903
Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantationtreatment2completed
NCT00325403
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)treatment3completed
NCT00491803
Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD)treatment4completed
NCT04589390
Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertensiontreatment2unknown_status
NCT04565990
A Study of Selexipag in Participants Who Participated in a Previous Selexipag Studytreatment3completed
NCT01824290
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)treatment3completed
NCT00334490
Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?treatment2completed
NCT04624490
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Diseasediagnostic1recruiting
NCT05447390
Evaluation of the Strength of Handgrip in Patients With Pulmonary Artery HypertensionNo drug interventionsdiagnosticNot Availableunknown_status
NCT01275690
Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization With Acute Vasodilator TestingNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04732221
A Study of the Efficacy and Safety of MK-5475 in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)No drug interventionstreatment2 / 3completed
NCT00678821
Aerobic Exercise in Patients With Pulmonary HypertensionNo drug interventionssupportive_care2completed
NCT02661802
Effects Oxygen Supplementation Determined Better Exercise Capacity in Eisenmenger SyndromeNo drug interventionssupportive_careNot Availablecompleted
NCT05827302
Integrating ePReBMs From Phoenix in Respiratory DiseasesNo drug interventionsotherNot Availablerecruiting
NCT02576002
Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)No drug interventionsNot AvailableNot Availablecompleted
NCT01607502
Database for Clinical and Anamnestic Data in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT03146702
Turkish Translation of The Emphasis-10 QuestionnaireNo drug interventionsNot AvailableNot Availablecompleted
NCT04744584
Medication Reconciliation in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT04947384
Pulmonary Vascular Hemodynamics Before and After Mitral Valve ProceduresNo drug interventionsNot AvailableNot Availablerecruiting
NCT02429284
U.S. CTEPH RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT01038284
Multidisciplinary Collaboration Care in Pulmonary Arterial Hypertension (PAH)No drug interventionsNot AvailableNot Availablecompleted
NCT01410279
Inspiratory Muscle Training in Pulmonary HypertensionNo drug interventionstreatmentNot Availableunknown_status
NCT03637179
Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo) Under ExerciseNo drug interventionspreventionNot Availablecompleted
NCT00625079
Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafiltreatment4withdrawn
NCT04792879
Assessment of Peripheral Veins Doppler Ultrasound for Diagnosis of Acute Right Heart Failure in Suspicion or Follow-up of Pulmonary HypertensionNo drug interventionsdiagnosticNot Availablecompleted
NCT05896579
Identifying Right Ventricular Dysfunction in COPD Through Right Heart Catheterization, Imaging and ExerciseNo drug interventionsotherNot Availablerecruiting
NCT04088279
Novel Quantitative Magnetic Resonance Imaging (MRI) Measures in the Assessment and Follow-up of Patients With Pulmonary Hypertension (PH)No drug interventionsdiagnosticNot Availableunknown_status
NCT00133679
Chronic Sildenafil for Severe Diaphragmatic Herniatreatment4terminated
NCT00075179
Natrecor in Pulmonary Hypertensiontreatment4terminated
NCT00581087
Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adultstreatment3unknown_status
NCT02986087
Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic HerniaNo drug interventionstreatmentNot Availablerecruiting
NCT03901287
Quantitative Dual Energy Computed Tomography in Pulmonary HypertensionNo drug interventionsdiagnosticNot Availablecompleted
NCT00190333
Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertensiontreatment3completed
NCT05937854
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PHtreatment2recruiting
NCT04615754
Ketones for Pulmonary Hypertension - Effects on HemodynamicsNo drug interventionstreatment2completed
NCT00004754
Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertensiontreatment4completed
NCT04891354
A First-in-Human Study to Assess the Safety and Tolerability of PDNONo drug interventionstreatment1completed
NCT00680654
Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TIDtreatment1completed
NCT01260454
The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Paintreatment2completed
NCT01065051
Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kineticstreatment2terminated
NCT04689451
Feasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00675051
Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT05176951
A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Diseasetreatment2completed
NCT01028651
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary HypertensionNot AvailableNot Availablecompleted
NCT01023451
Serum Brain Natriuretic Peptide Levels and Pulmonary Hypertension in Pediatric Sickle Cell PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03727451
A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or SarcoidosisNo drug interventionstreatment2completed
NCT03581851
Acute Exposure of Simulated Hypoxia on ECG and Non-invasive Blood PressureNo drug interventionspreventionNot Availablecompleted
NCT01204853
A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patientstreatment3terminated
NCT03637153
Acute Exposure to High Altitude on Exercise CapacityNo drug interventionspreventionNot Availablecompleted
NCT05427253
First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy SubjectsNo drug interventionsbasic_science1completed
NCT02551653
Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patientsother1completed
NCT04729777
Assessment of Cardiac Function Using Combined Cardiovascular Magnetic Resonance and Cardiopulmonary Exercise Testing (CMR-CPET)No drug interventionsNot AvailableNot Availableunknown_status
NCT02485977
Cardiac MRI in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT01913847
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertensiontreatment3unknown_status
NCT06351345
129 Xenon Imaging in Patients Treated With Sotaterceptdiagnostic2not_yet_recruiting
NCT04402645
Novel Echocardiographic Methods for Early Identification of Neonates at Risk for Chronic Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT02755298
Chronic Clinical Effect of Acetazolamidetreatment2 / 3completed
NCT03134898
Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT02748798
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disordersdiagnostic0recruiting
NCT01048905
Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertensiontreatment2completed
NCT00644605
A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertensiontreatment3completed
NCT05636397
Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NECNo drug interventionstreatmentNot Availablerecruiting
NCT03997097
Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Diseasetreatment3withdrawn
NCT03794583
Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)treatment3terminated
NCT02217683
Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusiontreatment2withdrawn
NCT01399983
Standardization of 6 Minute Walk TestNo drug interventionsNot AvailableNot Availablecompleted
NCT00452283
Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT04555161
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension SystemNo drug interventionstreatmentNot Availablerecruiting
NCT00159861
The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAHtreatment3completed
NCT05843461
PIMR and Pulmonary Vascular DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT05856461
Pulmonary Artery Denervation in Patients With Atrial Fibrillation and Group 2 of Pulmonary HypertensionNo drug interventionstreatmentNot Availablerecruiting
NCT02339961
Evaluating Pulmonary Arterial Hypertension in Patients With Systemic SclerosisNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00780728
Study Evaluating the Addition of Sildenafil to Bosentan Therapy in Pulmonary Arterial HypertensionNot Available3withdrawn
NCT02243111
Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by UltrasoundNo drug interventionsdiagnosticNot Availableterminated
NCT06031311
Pulmonaryhypertension in Copd at Different Levels of SmokingNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01126411
Immunoadsorption in Patients With Pulmonary HypertensionNo drug interventionstreatment1 / 2withdrawn
NCT05001711
Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT00319111
Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)treatment3completed
NCT03630211
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosistreatment2recruiting
NCT01783093
Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell AnemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00810693
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)treatment3completed
NCT02633293
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFEtreatment2 / 3terminated
NCT02275793
The Regulation of Pulmonary Vascular Resistance in Patients With Heart FailureNo drug interventionsNot AvailableNot Availablecompleted
NCT01234571
Impact of Hemo-dialysis Therapy on Blood Levels of Treprostenil in End Stage Renal Disease Patients With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT01621971
Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patientstreatment3completed
NCT01468571
Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertensiontreatment4unknown_status
NCT06240871
Contrast Enhanced PA Pressure MeasurementsNo drug interventionsNot AvailableNot Availablecompleted
NCT03565471
Atrial Septal Defect - Exercise Capacity and Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT03935178
Evaluating Right Ventricular (RV) Size and Function Using the Upper Valley RV Algorithm and Novel Imaging ModalitiesNo drug interventionsNot AvailableNot Availableterminated
NCT02237378
A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart DiseaseNo drug interventionsbasic_scienceNot Availableterminated
NCT00432978
Effect of Bosentan on Exercise Capacity at High Altitudetreatment1completed
NCT00878878
Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).diagnostic4completed
NCT00887978
Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertensiontreatment3completed
NCT03626688
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patientstreatment3recruiting
NCT04197388
Inspiratory Muscle Training in Pulmonary Arterial HypertensionNo drug interventionstreatmentNot Availableunknown_status
NCT00454207
Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertensiontreatment3completed
NCT03293407
Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial HypertensionNot AvailableNot Availablecompleted
NCT06174207
Hyperoxia During Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?No drug interventionstreatmentNot Availablerecruiting
NCT00034307
Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertensiontreatment2 / 3unknown_status
NCT03030807
Pulmonary Hypertension in Hypersensitivity PneumonitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00105209
A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertensiontreatment2completed
NCT03876509
Non-invasive Diagnosis of Pulmonary Hypertension by Impedance CardiographyNo drug interventionsNot AvailableNot Availablecompleted
NCT06135909
CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02129309
Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery PressuresNo drug interventionspreventionNot Availablecompleted
NCT01972009
Wave Intensity Analysis in the Pulmonary ArteryNo drug interventionsNot AvailableNot Availableunknown_status
NCT04188756
RV Systolic and Diastolic Function and Contractile Reserve Under Acute Exercise and in Response to Chronic Exercise-based RehabilitationNo drug interventionstreatmentNot Availableunknown_status
NCT01586156
PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)treatmentNot Availablecompleted
NCT01682356
Dietary Nitrates for Heart Failure (HF)No drug interventionstreatment1 / 2active_not_recruiting
NCT00240656
Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertensiontreatment1completed
NCT00718185
Pharmacokinetics and Pharmacdynamics of SildenafilNo drug interventionsNot AvailableNot Availableterminated
NCT03576885
Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasiaprevention1 / 2terminated
NCT02428985
Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)Not AvailableNot Availablecompleted
NCT03600415
Acute Exposure to High Altitude on Blood and Tissue Oxygenation (ABGA, NIRS)No drug interventionspreventionNot Availablecompleted
NCT01607515
Non Invasive Measurement of Cardiac Index by Impedance CardiographyNo drug interventionsdiagnosticNot Availablecompleted
NCT05719415
Assessment of Recovery of Functional Capillary Surface Area in Patients Undergoing a Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary HypertensionNo drug interventionsbasic_scienceNot Availablerecruiting
NCT00640315
Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.treatment1completed
NCT00091715
Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class IItreatment3completed
NCT00566137
Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma PatientNo drug interventionsNot AvailableNot Availablecompleted
NCT00909337
Early Therapy of Pulmonary Arterial HypertensiontreatmentNot Availablecompleted
NCT02570737
Latin American Pulmonary Hypertension RegistryNo drug interventionsNot AvailableNot Availableunknown_status
NCT04262037
A Comparative Study of Three Modes of Ventilation During CPB in Pediatrics With Pulmonary Hypertension Undergoing Congenital Heart SurgeriesNo drug interventionssupportive_careNot Availableunknown_status
NCT01313832
The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary HypertensionNo drug interventionspreventionNot Availablecompleted
NCT00464932
Vasoactive Intestinal Peptide in COPDNot AvailableNot Availablecompleted
NCT03270332
Effect of Inhaled Albuterol in Pulmonary Hypertensiontreatment2completed
NCT01961232
Trans-pulmonary Biomarkers in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02826252
Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)Not AvailableNot Availablecompleted
NCT01305252
A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).treatment4completed
NCT00113152
Heart Disease in Sickle Cell AnemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT06568952
Right Ventricular Function in Patients Taking CarfilzomibNo drug interventionsNot AvailableNot Availablecompleted
NCT00614900
Prevalence of Pulmonary Hypertension in COPD PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02755259
Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertensiontreatment2 / 3completed
NCT02768259
Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02223559
Non-invasive Assessment of Pulmonary Artery PressureNo drug interventionsNot AvailableNot Availablecompleted
NCT01273259
Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adultstreatment2completed
NCT06581159
Study of HS135 in Obese Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection FractionNo drug interventionstreatment1not_yet_recruiting
NCT04697875
Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary HypertensionNo drug interventionsotherNot Availablecompleted
NCT01637675
Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertensiontreatment2 / 3unknown_status
NCT02036970
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIATtreatment2completed
NCT03460470
Sildenafil in US Heart Failure Patients (SilHF-US)treatment3unknown_status
NCT01104870
A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertensiontreatment2completed
NCT00325442
FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)treatment3completed
NCT01241942
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant SuitabilityNo drug interventionsdevice_feasibilityNot Availableterminated
NCT02966899
Reversal of Right Ventricular Steatosis in Pulmonary HypertensionNo drug interventionsdiagnosticNot Availablewithdrawn
NCT04498299
Stress Echocardiography in Patients Recovery From Mild COVID-19 IllnessNo drug interventionsNot AvailableNot Availableunknown_status
NCT01484899
Smoking: a Risk Factor for Pulmonary Arterial Hypertension?No drug interventionsNot AvailableNot Availablecompleted
NCT05679206
Antiphospholipid Syndrome and Postpartum Pulmonary Artery PressureNo drug interventionsNot AvailableNot Availablerecruiting
NCT01135706
Fractal Analysis of the Pulmonary Arterial Tree in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT05198206
Pregnant Women With Pulmonary Hypertension in ChinaNo drug interventionsNot AvailableNot Availableunknown_status
NCT01932606
Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fractiontreatment2completed
NCT02378649
PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertensiontreatment4completed
NCT02789449
Estimation of Pulmonary Capillary Blood Volume in Pre- and Postcapillary Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT01726049
Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PHtreatment3completed
NCT02844036
Angioplasty of Distal Lesions for Carriers of Inoperable Post-embolic HTPNo drug interventionstreatmentNot Availablecompleted
NCT03572036
Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT00540436
Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertensiontreatment2completed
NCT01571713
Side Effects of Pulmonary Hypertension MedicationsNo drug interventionsNot AvailableNot Availablecompleted
NCT06186713
Pulmonary Hypertension on Prognosis of Acute Myocardial Infarction Patients With Reduced Left Ventricular FunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT04715113
Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT00001313
Evaluation of Patients With Known or Suspected Heart DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01431313
Inhaled Nitrite in Subjects With Pulmonary Hypertensiontreatment2completed
NCT00180713
Simvastatin as a Treatment for Pulmonary Hypertensiontreatment1 / 2completed
NCT03637218
Acute Exposure of High Altitude on Cardiac OutputNo drug interventionspreventionNot Availablecompleted
NCT05267418
Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise ToleranceNo drug interventionssupportive_careNot Availableterminated
NCT02092818
EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary HypertensionNot AvailableNot Availablecompleted
NCT05665218
Comparison of Different Cardiac Output Measurement Methods in Patients Undergoing Right Heart CatheterizationNo drug interventionsNot AvailableNot Availablerecruiting
NCT02170519
Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxidetreatment4terminated
NCT02759419
A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.treatment4recruiting
NCT00046319
Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertensiontreatment2completed
NCT01598441
Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)treatment3completed
NCT02595541
Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary Hypertensiontreatment1 / 2completed
NCT00139217
NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the NewbornNo drug interventionstreatmentNot Availablecompleted
NCT02536534
Electronic Activity Level Monitoring Pilot in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT01441934
SPHERIC-1. Sildenafil and Pulmonary HypERtension In COPDtreatment3unknown_status
NCT04145024
Giessen Pulmonary Hypertension Registry and BiobankNo drug interventionsNot AvailableNot Availablerecruiting
NCT00679224
An Observational Study For AmbrisentanNot AvailableNot Availablecompleted
NCT06409624
Association Between Biomarkers and eGFR Decline in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT00323024
Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial HypertensionNo drug interventionstreatment2withdrawn
NCT00760916
FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)treatment3withdrawn
NCT02560116
The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler SignalsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03459716
Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT03955016
Rehabilitation for Patients With Pulmonary HypertensionNo drug interventionstreatmentNot Availableunknown_status
NCT00467896
The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Settingtreatment2terminated
NCT03593096
Acute Exposure to High Altitude on Heart Rate and Ventilation During ExerciseNo drug interventionspreventionNot Availablecompleted
NCT04808596
Pulmonary Hypertension Biorepository and RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT01076296
A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging SystemNo drug interventionsNot AvailableNot Availablecompleted
NCT05572996
Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung DiseaseNot AvailableNot Availableavailable
NCT01121458
Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Beddiagnostic4completed
NCT05918458
Discovering Clinical Study Experiences of Patients With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01781858
Study on the Clinical Course Of Pulmonary EmbolismNo drug interventionsNot AvailableNot Availablecompleted
NCT05612035
MK-5475-013 INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of MK-5475 (an Inhaled sGC Stimulator) in Adults With PH-COPDNo drug interventionstreatment2recruiting
NCT04769635
CPAP Therapy in Obstructive Sleep Apnea Patients With Pulmonary HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT00625963
The Study Of CT Scans and Echo Parameters in Patients With PAHNo drug interventionsNot AvailableNot Availablecompleted
NCT03051763
The Effects of Commercial Air Travel on Patients Suffering From Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT06416163
FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01725763
Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary HypertensionNo drug interventionsdiagnosticNot Availableenrolling_by_invitation
NCT02024386
Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitudeother4completed
NCT00082186
The Effect of Tracleer® on Male Fertilitytreatment4completed
NCT00811486
Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular FailuretreatmentNot Availablewithdrawn
NCT02775539
Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failuretreatment2unknown_status
NCT03077139
Cardiac Resynchronization Therapy in Pulmonary HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT02120339
Carvedilol PAH A Pilot Study of Efficacy and Safetybasic_science1terminated
NCT01606839
Noninvasive Measurement of Cardiac Output in Pulmonary Hypertension Using Inert Gas RebreathingNo drug interventionsNot AvailableNot Availablecompleted
NCT00795639
Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)treatment3terminated
NCT02873039
Correlation Between Estimated Right Atrial Pressure and BNP in Pulmonary HTN (CRAB-PH)No drug interventionsNot AvailableNot Availablecompleted
NCT05746039
Feasibility of Semaglutide in Advanced Lung Diseasetreatment1 / 2recruiting
NCT02744339
Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fractiontreatment2completed
NCT01979822
LenusPro Safety (LPS) Study in Patients With PHNo drug interventionsNot AvailableNot Availableunknown_status
NCT03092622
Aerobic Interval Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) and HypoxemiaNo drug interventionsotherNot Availablecompleted
NCT01163422
Right Ventricular Resynchronization TherapyNo drug interventionstreatmentNot Availableunknown_status
NCT04224025
Training Single ArmNo drug interventionstreatmentNot Availablerecruiting
NCT06050525
Incidence of Acute Kidney Injury and Risk Factors in Newborns With Congenital Diaphragmatic HerniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT02331225
Endothelial Microparticles in Systemic Sclerosis Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT00310830
Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)treatment3terminated
NCT02050230
Hemodynamic Effects of Stored Blood Transfusion in Intensive Care PatientsNo drug interventionstreatment4terminated
NCT03068130
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGERtreatment3terminated
NCT03122730
VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPBtreatment2completed
NCT01418248
Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01523548
Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertensiontreatment1 / 2withdrawn
NCT01840748
Development and Prevention of Pulmonary Hypertension in Systemic SclerosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00011648
Secondary Pulmonary Hypertension in Adults With Sickle Cell AnemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT02078557
A Multiple Dose Titration Study of MK-8892 in Participants With Pulmonary Hypertension and Left Heart Disease (MK-8892-007)No drug interventionstreatment1terminated
NCT05523557
Urban-training Intervention in Pulmonary Hypertension (UTHAP)No drug interventionstreatmentNot Availablerecruiting
NCT02777957
Predictors of Pulmonary Hypertension in Patients With Advanced Lung DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT00005357
Pulmonary Hypertension--Mechanisms and Family RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT05478226
ADAMTSL4 in Idiopathic Pulmonary Hypertension and CTEPHNo drug interventionsNot AvailableNot Availablecompleted
NCT01287026
Real-time MRI Right Heart Catheterization Using Passive CathetersNo drug interventionsdiagnostic1 / 2completed
NCT00409526
Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.treatment4terminated
NCT02782026
Exhaled Breath Olfactory Signature of Pulmonary Arterial HypertensionNo drug interventionsdiagnosticNot Availablecompleted
NCT03637166
Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo)No drug interventionspreventionNot Availablecompleted
NCT00796666
Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafiltreatment3terminated
NCT00637065
Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Studytreatment4unknown_status
NCT00855465
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.treatment3completed
NCT00345774
Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Diseasetreatment2completed
NCT01554774
Non-invasive Assessment of Pulmonary Vascular Resistance in Elderly Patients With Chronic Obstructive Pulmonary DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01884974
A Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases.No drug interventionsNot AvailableNot Availableunknown_status
NCT03396120
The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT05256082
Impact of Face Masks on 6MWD in Patients With Pulmonary HypertensionNo drug interventionsdiagnosticNot Availablecompleted
NCT01062282
Hypertension Study of Ventavis® Inhalation Therapy in the Treatment of Patients With Pulmonary Arterial Hypertension (VENIS)Not AvailableNot Availablecompleted
NCT06362382
Mobile Internet-based Remote Home Rehabilitation Improves Prognostic Function and Life Quality in Pulmonary HypertensionNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00352482
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertensiontreatment2completed
NCT03810482
Pedometers and Walking Tests for Pulmonary Hypertension PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT00706082
Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)No drug interventionsNot AvailableNot Availableterminated
NCT02571231
High Flow Ventilation With Volume GuaranteeNo drug interventionstreatmentNot Availableunknown_status
NCT05610631
Pulmonary Hypertension Registry SwitzerlandNo drug interventionsNot AvailableNot Availablerecruiting
NCT02026531
Novel MRI Techniques in the Evaluation of Pulmonary Vascular DiseaseNo drug interventionsdiagnostic1 / 2completed
NCT01332331
Efficacy and Safety of Ambrisentan in Children 8-18yrstreatment2terminated
NCT02984631
The Evaluation and Treatment of Elevated Left-Sided Filling Pressures by Balloon Inflation Within the IVCNo drug interventionsdiagnosticNot Availableunknown_status
NCT01178073
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)treatment3completed
NCT06570473
Feasibility Trial for a Right Ventricular Failure Platform Trialtreatment2not_yet_recruiting
NCT03377673
Right Ventricular and Pulmonary Artery Evaluation by CMRNo drug interventionsNot AvailableNot Availableunknown_status
NCT00005773
Early Inhaled Nitric Oxide for Respiratory Failure in Newbornstreatment3terminated
NCT03155373
The Right Ventricular Pulmonary Circulation Continuum in Mitral Valve Disease StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04370873
MK-5475 in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006)No drug interventionstreatment1completed
NCT03371173
ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)treatment3terminated
NCT04071327
Pulmonary Hypertension Association RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00926627
Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosistreatment2terminated
NCT03890627
Thoracic Bio-reactance Measurement of Cardiac Output in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT03592927
Acute Exposure to Simulated Hypoxia on Exercise CapacityNo drug interventionspreventionNot Availablecompleted
NCT01725776
Inhaled Milrinone in Cardiac Surgeryprevention2completed
NCT05179876
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Optiontreatment3recruiting
NCT01467076
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)treatment2terminated
NCT03388476
Endtidal Carbon Dioxide for Earlier Detection of Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT03043976
Using Step Count to Enhance Daily Physical Activity in Pulmonary HypertensionNo drug interventionstreatmentNot Availableterminated
NCT04554160
Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac MonitoringNo drug interventionsNot AvailableNot Availablerecruiting
NCT02610660
Tracking Outcomes and Practice in Pediatric Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT02299960
Measurement of Endothelial Function and Cardiac Output: New MethodsNo drug interventionsNot AvailableNot Availablecompleted
NCT02712294
Impact of NMES on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT03667794
Evaluation of Novel Lung Function Parameters in Patients With Pulmonary Hypertension (PH)No drug interventionsNot AvailableNot Availablecompleted
NCT01467791
Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)No drug interventionsNot AvailableNot Availableunknown_status
NCT02070991
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunctiontreatment2completed
NCT05343091
Prognostic Value of the Right Ventricular Function by Portable Ultrasound in Patients With Pulmonary Hypertension.No drug interventionsNot AvailableNot Availableunknown_status
NCT04842591
Characteristics of Pulmonary Vascular Changes in Patients With Kidney TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04391491
Neuregulin-1 in Patient With Different Forms of Cardiovascular Diseases: a Pilot StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT03464591
Cardiac Speckle Tracking Myocardial Strain BalanceNo drug interventionsNot AvailableNot Availableunknown_status
NCT03013062
Relation Between Mean Pulmonary Artery Pressure and Pulmonary Acceleration Time and Comparison With Previous FormulaeNo drug interventionsNot AvailableNot Availableunknown_status
NCT05996562
Study for Evaluation of Safety and Efficacy of PADN to Treat Combined Post- and Pre- Capillary Pulmonary Hypertension Associated With Chronic Heart FailureNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05844462
Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Diseasetreatment3recruiting
NCT01784562
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Not AvailableNot Availableno_longer_available
NCT06443580
Interoceptive Intervention for Pulmonary HypertensionNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT04594629
PGI2 Versus Nitroglycerine for Management of Pulmonary Hypertension After Valve Surgeriestreatment1unknown_status
NCT00058929
A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertensiontreatment4completed
NCT00820729
Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT05128929
Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).treatment2completed
NCT00851929
Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertensiontreatment2 / 3completed
NCT03310229
Pulmonary Hypertension in Haemodialysis Patients :Frequency and Risk FactorsNo drug interventionsNot AvailableNot Availablecompleted
NCT00598429
Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failuretreatment2withdrawn
NCT05103189
4D-flow Cardiac MRI to Assess Pulmonary Arterial Pressure in Pulmonary HypertensionNo drug interventionsdiagnosticNot Availablecompleted
NCT01910389
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failuretreatment3terminated
NCT05387889
Piloting Mindfulness Meditation Program for Underserved Racial Minority Adults With Pulmonary HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT05550389
Genetics of Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT06373289
Target Oxygen Ranges in Infants With Pulmonary HypertensionNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03637192
Acute Exposure of High Altitude on Cognitive FunctionNo drug interventionspreventionNot Availablecompleted
NCT00800592
Sildenafil IV Bolus Studytreatment1completed
NCT01306292
Safety of SonoVue on Pulmonary HemodynamicsNot Available2completed
NCT03404492
Effects of Cardiorespiratory Rehabilitation on the Right Ventricle in Pulmonary HypertensionNo drug interventionsotherNot Availablecompleted
NCT00423592
Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertensiontreatment2completed
NCT01730092
Natural History Study of Biomarkers in Pulmonary Arterial HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05201144
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)treatment2recruiting
NCT00538044
Simvatstatin Used to Treat Pulmonary Hypertensiontreatment1unknown_status
NCT04704440
Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without SildenafilNo drug interventionstreatmentNot Availablecompleted
NCT04293640
Neural Respiratory Drive in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT00875940
Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation AnalysisNo drug interventionsNot AvailableNot Availablecompleted
NCT00250640
Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 YearsNot AvailableNot Availablecompleted
NCT03629340
Metformin for Pulmonary Hypertension HFpEFtreatment2recruiting
NCT00909467
Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT01394367
Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary HypertensionNo drug interventionssupportive_careNot Availablecompleted
NCT05958901
Pulmonary Hypertension Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00963001
Effect of Food on the Pharmacokinetics of Oral Treprostiniltreatment1completed
NCT00457301
Using Health-related Quality of Life (HRQL) in Routine Clinical CareNo drug interventionsNot AvailableNot Availablecompleted
NCT05903001
Diaphragmatic Function as a BiomarkerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02951104
Noninvasive Cardiac Output Monitoring in Pulmonary HypertensionNo drug interventionsdiagnosticNot Availablecompleted
NCT00643604
Rapid Switch From Flolan to Remodulin in the Outpatient Clinictreatment4terminated
NCT03185572
Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Hypertension in ChinaNo drug interventionsNot AvailableNot Availableunknown_status
NCT03039972
Changes in Renal Function and Body Composition in Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT03926572
Acute Decompensation of Pulmonary HypertensionNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT02324868
Impact of Availability of Showerpatch for Patients With Intravenous CathetersNo drug interventionssupportive_careNot Availableterminated
NCT01469169
Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Studytreatment3completed
NCT00850369
A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary HypertensionNo drug interventionstreatment2withdrawn
NCT03133169
Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT00986869
The Safety of Flexible Bronchoscopy in Patients With Pulmonary HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT05726669
Self-help Booklets for Depression in Adults With Pulmonary Hypertension.No drug interventionstreatmentNot Availablecompleted
NCT04193046
A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)No drug interventionsdiagnostic0completed
NCT04753112
Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Devicetreatment3completed
NCT04993612
Postcapillary Blood Gas Analysis in Wedge Position (Wedge-BGA)No drug interventionsNot AvailableNot Availablerecruiting
NCT01091012
Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary HypertensionNot Available3unknown_status
NCT04224012
Effect of Exercise and Respiratory Therapy on Right Ventricular Function in Severe Pulmonary HypertensionNo drug interventionsotherNot Availableunknown_status
NCT02892981
Dead Space Evaluation in Pulmonary HypertensionNo drug interventionsdiagnosticNot Availablecompleted
NCT05655481
Telerehabilitation Program Via Videoconference PAH - Randomized Clinical TrialNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01274481
Iloprost Effects on Gas Exchange and Pulmonary Mechanicstreatment1completed
NCT02223481
Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertensiontreatment2completed
NCT00109681
Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosistreatment2completed
NCT03317314
Cardiopulmonary Interactions in Patients With Heart FailureNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03637114
Acute Exposure of Simulated Hypoxia on Blood and Tissue Oxygenation (aBGA, NIRS)No drug interventionspreventionNot Availablecompleted
NCT00946114
To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 WeeksNot AvailableNot Availablecompleted
NCT01463514
Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary HypertensionNo drug interventionsdiagnosticNot Availablecompleted
NCT05329714
PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT02267655
3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPFtreatment1completed
NCT00377455
Placebo Controlled Trial of Bosentan in Scleroderma Patientstreatment2terminated
NCT02305550
A Proof of Concept Study of Electrical Discharge Produced Nitric Oxide for InhalationNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT05983250
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFNo drug interventionstreatment3recruiting
NCT04008550
Prognostic Impact of the Evolution of PAH 3 Months After TAVI (HTP-TAVI)No drug interventionsotherNot Availableterminated
NCT02637050
A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA CountriesNo drug interventionsNot AvailableNot Availablecompleted
NCT04857450
Anesthesia for Upper Endoscopy and Colonoscopy in Cardiac Patients With Acute Anemiasupportive_careNot Availableunknown_status
NCT01112150
Effect of Normatec Pump for Relief of Leg EdemaNo drug interventionssupportive_careNot Availableunknown_status
NCT01481350
Sildenafil for Post-capillary Pulmonary Hypertension in Patients Undergoing Cardiac Surgerytreatment2completed
NCT05824923
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart FailureNo drug interventionstreatment3recruiting
NCT00615823
Atorvastatin in Pulmonary Hypertensiontreatment2completed
NCT00000623
Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)Not AvailableNot Availablecompleted
NCT00367523
Pulmonary Hypertension in Patients With Sickle Cell Disease in NigeriaNo drug interventionsNot AvailableNot Availablecompleted
NCT05798923
A Phase 2a Study of LAM-001 for the Treatment of Pulmonary HypertensionNo drug interventionstreatment2recruiting
NCT01100008
Cardiac Magnetic Resonance Imaging and Pulmonary PerfusionNo drug interventionsdiagnosticNot Availablecompleted
NCT02403908
Catheter Denervation of Pulmonary Arteries in Treatment of IPAH & SPAHNo drug interventionstreatment1unknown_status
NCT02999438
Frailty in Children With Cardiac DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01072643
Sedation With Dexmedetomidine During Cardiac Catheterizationtreatment2 / 3terminated